Boehringer Ingelheim
Breast cancer is the most common cancer among women worldwide, and the leading cause of cancer deaths among women.1
90% of all women diagnosed with breast cancer will be alive 5 years after diagnosis.2 This is due to major achievements over the past 40 years. Awareness has increased dramatically; diagnosis, treatment and management of breast cancer have improved.
The stage at which breast cancer is diagnosed has a significant impact on the type of treatment used and on the prognosis of the disease. Early diagnosis is essential to ensure better outcomes.
Learn more about breast cancer symptoms and staging by launching our interactive infographic above. Bookmark this page and check back for regular updates to the breast cancer story.
Source for healthcare professionals: www.inoncology.com
* Nintedanib (BIBF 1120), afatinib (BIBW 2992) and volasertib (BI 6727) are investigational compounds. Their safety and efficacy have not yet been fully established.